These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
142 related articles for article (PubMed ID: 35205660)
1. Heterogeneity of Small Intestinal Neuroendocrine Tumors Metastasis: Biologic Patterns of a Series with Virchow's Node Involvement. Wedin M; Tsoli M; Wallin G; Janson ET; Koumarianou A; Kaltsas G; Daskalakis K Cancers (Basel); 2022 Feb; 14(4):. PubMed ID: 35205660 [TBL] [Abstract][Full Text] [Related]
2. Association of lymph node metastases, grade and extent of mesenteric lymph node dissection in locoregional small intestinal neuroendocrine tumors with recurrence-free survival. Daskalakis K; Wedin M; Tsoli M; Kogut A; Srirajaskanthan R; Sarras K; Kattiparambil S; Giovos G; Weickert MO; Kos-Kudla B; Kaltsas G J Neuroendocrinol; 2022 Nov; 34(11):e13205. PubMed ID: 36385444 [TBL] [Abstract][Full Text] [Related]
3. Prevalence of metastases outside the liver and abdominal lymph nodes on Wedin M; Janson ET; Wallin G; Sundin A; Daskalakis K J Neuroendocrinol; 2024 May; 36(5):e13391. PubMed ID: 38590270 [TBL] [Abstract][Full Text] [Related]
4. Prognostic differences in grading and metastatic lymph node pattern in patients with small bowel neuroendocrine tumors. Reinhard L; Mogl MT; Benz F; Dukaczewska A; Butz F; Dobrindt EM; Tacke F; Pratschke J; Goretzki PE; Jann H Langenbecks Arch Surg; 2023 Jun; 408(1):237. PubMed ID: 37332044 [TBL] [Abstract][Full Text] [Related]
5. Association of a Prophylactic Surgical Approach to Stage IV Small Intestinal Neuroendocrine Tumors With Survival. Daskalakis K; Karakatsanis A; Hessman O; Stuart HC; Welin S; Tiensuu Janson E; Öberg K; Hellman P; Norlén O; Stålberg P JAMA Oncol; 2018 Feb; 4(2):183-189. PubMed ID: 29049611 [TBL] [Abstract][Full Text] [Related]
6. Lung Metastases in Patients with Well-Differentiated Gastroenteropancreatic Neuroendocrine Neoplasms: An Appraisal of the Validity of Thoracic Imaging Surveillance. Daskalakis K; Tsoli M; Srirajaskanthan R; Chatzellis E; Alexandraki K; Angelousi A; Pizanias M; Randeva H; Kaltsas G; Weickert MO Neuroendocrinology; 2019; 108(4):308-316. PubMed ID: 30673674 [TBL] [Abstract][Full Text] [Related]
7. [Analysis of clinicopathological characteristics, therapeutic strategy and prognosis of 501 patients with gastric neuroendocrine neoplasms attending a single center]. Zhang BL; Lu YX; Liang WQ; Gao YH; Xi HQ; Wang XX; Zhang KC; Chen L Zhonghua Wei Chang Wai Ke Za Zhi; 2023 May; 26(5):459-466. PubMed ID: 37217354 [No Abstract] [Full Text] [Related]
8. Pancreatic metastases in patients with neuroendocrine neoplasms: A multi-centre cohort study. Tsoli M; Daskalakis K; Wedin M; Angelousi A; Povlsen S; Srirajaskanthan R; Giovos G; Weickert MO; Kogut A; Kos-Kudla B; Oleinikov K; Grozinsky-Glasberg S; Kaltsas G J Neuroendocrinol; 2023 Apr; 35(4):e13269. PubMed ID: 37102337 [TBL] [Abstract][Full Text] [Related]
9. Isolated synchronous Virchow lymph node metastasis of sigmoid cancer: A case report. Yang JQ; Shang L; Li LP; Jing HY; Dong KD; Jiao J; Ye CS; Ren HC; Xu QF; Huang P; Liu J World J Clin Cases; 2021 Nov; 9(32):9917-9925. PubMed ID: 34877331 [TBL] [Abstract][Full Text] [Related]
10. Long-term results of surgery for small intestinal neuroendocrine tumors at a tertiary referral center. Norlén O; Stålberg P; Öberg K; Eriksson J; Hedberg J; Hessman O; Janson ET; Hellman P; Åkerström G World J Surg; 2012 Jun; 36(6):1419-31. PubMed ID: 21984144 [TBL] [Abstract][Full Text] [Related]
11. Modified Histopathological Grading Optimizes Prediction of Survival Outcomes in Small Intestinal Neuroendocrine Tumors. Daskalakis K; Tsoli M; Wallin G; Kogut A; Srirajaskanthan R; Harlow C; Giovos G; Weickert MO; Kos-Kudla B; Kaltsas G J Clin Endocrinol Metab; 2024 Nov; 109(12):e2222-e2230. PubMed ID: 38415861 [TBL] [Abstract][Full Text] [Related]
12. Relevant prognostic factors in patients with stage IV small intestine neuroendocrine neoplasms. Maurer E; Heinzel-Gutenbrunner M; Rinke A; Rütz J; Holzer K; Figiel J; Luster M; Bartsch DK J Neuroendocrinol; 2022 Jan; 34(1):e13076. PubMed ID: 34964186 [TBL] [Abstract][Full Text] [Related]
14. Surgical treatment of neuroendocrine tumors in the second portion of the duodenum: a single center experience and systematic review of the literature. Iwasaki T; Nara S; Kishi Y; Esaki M; Shimada K; Hiraoka N Langenbecks Arch Surg; 2017 Sep; 402(6):925-933. PubMed ID: 27915372 [TBL] [Abstract][Full Text] [Related]
15. Treatment patterns and oncological outcome of patients with advanced small intestinal neuroendocrine tumors: real-world data from the Medical University of Vienna. Melhorn P; Kretschmer-Chott E; Wolff L; Haug A; Mazal P; Raderer M; Kiesewetter B Ther Adv Med Oncol; 2022; 14():17588359221138389. PubMed ID: 36425874 [TBL] [Abstract][Full Text] [Related]
16. Clinical outcomes of gastroduodenal neuroendocrine tumors according to their WHO grade: A single-institutional retrospective analysis. Ryu DG; Kim SJ; Choi CW; Kang DH; Kim HW; Park SB; Nam HS; Lee SH; Hwang SH Medicine (Baltimore); 2022 Sep; 101(37):e30397. PubMed ID: 36123854 [TBL] [Abstract][Full Text] [Related]
17. Grade G2 Rectal Neuroendocrine Tumor Is Much More Invasive Compared With G1 Tumor. Li YW; He YP; Liu FQ; Peng JJ; Cai SJ; Xu Y; Wang MH Front Oncol; 2021; 11():646536. PubMed ID: 33777809 [TBL] [Abstract][Full Text] [Related]
18. Outcomes of Cytoreductive Surgery for Metastatic Low-Grade Neuroendocrine Tumors in the Setting of Extrahepatic Metastases. Chan DL; Dixon M; Law CHL; Koujanian S; Beyfuss KA; Singh S; Myrehaug S; Hallet J Ann Surg Oncol; 2018 Jun; 25(6):1768-1774. PubMed ID: 29560571 [TBL] [Abstract][Full Text] [Related]
19. Survival and prognostic factors analysis of 151 intestinal and pancreatic neuroendocrine tumors: a single center experience. Foubert F; Salimon M; Dumars C; Regenet N; Girot P; Venara A; Senellart H; Heymann MF; Matysiak-Budnik T; Touchefeu Y J Gastrointest Oncol; 2019 Feb; 10(1):103-111. PubMed ID: 30788165 [TBL] [Abstract][Full Text] [Related]
20. Para-aortic node involvement is not an independent predictor of survival after resection for pancreatic cancer. Sperti C; Gruppo M; Blandamura S; Valmasoni M; Pozza G; Passuello N; Beltrame V; Moletta L World J Gastroenterol; 2017 Jun; 23(24):4399-4406. PubMed ID: 28706422 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]